Pneumonia
Pneumonia is a respiratory condition. The evidence discussed here includes research from different clinical settings and examines different outcomes, so findings involving options such as Astragalus, Echinacea, Green Tea Extract (EGCG), or Selenium should not be treated as interchangeable or as applying to every person with pneumonia.
Pneumonia is classified as a respiratory condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
2 options:1 some evidence1 not enough evidence
AcupuncturepracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
A meta-analysis of 16 randomized trials reported improvements in inflammatory markers, pulmonary function, and symptom duration. One trial in 72 people also found improvements in symptoms, inflammatory markers, and pulmonary function when acupuncture was combined with breathing training.
Open the Acupuncture pageRed Light Therapy (Photobiomodulation)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A randomized trial of 30 people with community-acquired pneumonia reported improvements in pulmonary and clinical status when photobiomodulation was added to conventional therapy.
Open the Red Light Therapy (Photobiomodulation) page
May not suit people with this condition
Supplements and practices linked to problems for people with this condition.
Oil PullingpracticeUnclear
Two case reports described lipoid pneumonia associated with habitual sesame oil pulling.
Open the Oil Pulling page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition2 listedMost likely to help, from the evidence we have
- →PracticesAcupunctureCertaintyMediumSourceRCT
A meta-analysis of 16 randomized trials reported improvements in inflammatory markers, pulmonary function, and symptom duration. One trial in 72 people also found improvements in symptoms, inflammatory markers, and pulmonary function when acupuncture was combined with breathing training.
Who was studied
- People with a condition
- Pneumonia
- Stroke
Open AcupunctureStudy result
Meta-analysis of 16 RCTs showing significant improvements in effective rate, inflammatory markers, pulmonary function, and symptom duration.
Low probability(1)
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyLowSourceClinical
A randomized trial of 30 people with community-acquired pneumonia reported improvements in pulmonary and clinical status when photobiomodulation was added to conventional therapy.
Who was studied
- People with a condition
- Pneumonia
Open Red Light Therapy (Photobiomodulation)Study result
Trial enrolled 30 patients with CAP and reported improvements in pulmonary and clinical status with PBM adjunct to conventional therapy.
What to avoid
Interventions recorded as making it worse1 listedHighest probability
- →PracticesOil PullingCertaintyLowSourceClinical
Two case reports described lipoid pneumonia associated with habitual sesame oil pulling.
Who was studied
- People with a condition
- Pneumonia
Study result
Two case reports of lipoid pneumonia associated with habitual sesame oil pulling.
Open Oil PullingRationale
Two case reports of lipoid pneumonia associated with habitual sesame oil pulling.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Pneumonia is a respiratory condition. The evidence discussed here includes research from different clinical settings and examines different outcomes, so findings involving options such as Astragalus, Echinacea, Green Tea Extract (EGCG), or Selenium should not be treated as interchangeable or as applying to every person with pneumonia. Questions about treatment are best discussed with a clinician.
Evidence-backed options
The evidence for supplements associated with pneumonia is limited overall. It spans randomized controlled trials, clinical studies, a review, and theoretical rationale, but the findings do not establish a consistently effective option across people with pneumonia. The evidence also concerns different clinical settings and preparations, so results from one context may not apply broadly to others.
The options were not studied as one uniform treatment. The forms and routes varied, including traditional medicinal preparations, a solution, supplementation, and aerosol inhalation. The available summaries do not specify consistent doses, treatment durations, or how quickly effects appeared, so those details cannot be inferred. They also do not establish whether these options replace or alter standard pneumonia care.
Some findings address prevention or complications in particular settings rather than treatment of pneumonia itself, which is an important distinction when interpreting the options. The evidence should therefore be read as preliminary or context-specific rather than as confirmation of reliable benefit. Anyone considering these options for pneumonia should discuss them with a clinician, particularly because pneumonia can require prompt medical evaluation and treatment.